Liver Diseases: all 2,094 studies
Page 21 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Fatty Liver and Obstructive Sleep ApneaCompletedNCT00730873Not applicable
- De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver DiseaseCompletedNCT00714129Not applicable
- FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver DiseaseCompletedNCT00708617
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)Status unknownNCT00699036Phase 2
- Study of Fish Oil to Reduce ALT Levels in AdolescentsTerminatedNCT00694746Phase 1
- Improving Clinician Communication Skills (ICCS)CompletedNCT00687349Phase 3
- Quality of Life After Liver ResectionCompletedNCT00681499
- Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver DiseaseCompletedNCT00679692
- Pediatric Liver DatabaseCompletedNCT00677625
- A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT00677521Phase 2
- Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic ImpairmentCompletedNCT00672581Phase 1
- Effect of an Artificial Pancreas in Patients Undergoing Hepatic ResectionCompletedNCT00659698Phase 4
- Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron StoresStatus unknownNCT00658164Phase 3
- Effect of Preoperative Supplementation in Insulin ResistanceCompletedNCT00657124Phase 4
- Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver TransplantationTerminatedNCT00656266Phase 4
- Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT00655018Phase 2/3
- Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver DiseaseCompletedNCT00641524Not applicable
- Phase II Study of TRK-820 Soft Capsules - Intractable Pruritus in Patients With Chronic Liver Disease -CompletedNCT00638495Phase 2
- Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control StudyTerminatedNCT00637520
- HIV-HBV Co-Infection and Liver DiseaseStatus unknownNCT00637429
- Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver DiseaseCompletedNCT00633282Phase 2
- Genetic Polymorphisms of Interleukin-10 and TNF-α on Outcome of HCV-Related Chronic Liver DiseaseStatus unknownNCT00630006Not applicable
- Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver DiseaseStatus unknownNCT00629668Not applicable
- Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver DiseaseCompletedNCT00629603Not applicable
- Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular CarcinomaCompletedNCT00629486Not applicable
- A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy SubjectsCompletedNCT00621881Phase 1
- Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid TumoursCompletedNCT00621725Phase 1
- Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver DiseaseCompletedNCT00610597
- CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal ImpairmentCompletedNCT00604357Phase 3
- Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease PatientsTerminatedNCT00599352Not applicable
- Non Alcoholic Fatty Liver Disease (NAFLD) in Hong KongStatus unknownNCT00577044
- Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)SuspendedNCT00571272
- Lanreotide as Treatment of Polycystic LiversCompletedNCT00565097Phase 2/3
- A Study of Thymoglobulin and Tacrolimus in Liver TransplantStatus unknownNCT00564538Phase 4
- Efficacy of Multimodal Opioid Therapy During Hepatic Resection SurgeryStatus unknownNCT00553553Not applicable
- Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic DysfunctionTerminatedNCT00550849Phase 1/2
- Transoesophageal Echocardiography in Liver TransplantationCompletedNCT00547924
- Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant SurvivalCompletedNCT00531921
- Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver DiseaseCompletedNCT00529178Phase 4
- Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin SensitivityCompletedNCT00523562Not applicable
- Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)CompletedNCT00488917
- YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver TransplantationStatus unknownNCT00450398Phase 2
- Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative TrialTerminatedNCT00436722Phase 2
- Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.CompletedNCT00432627Phase 1
- Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver DiseaseCompletedNCT00402402Phase 4
- Phase I Trial of Silymarin for Chronic Liver DiseasesCompletedNCT00389376Phase 1
- A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study DrugCompletedNCT00382668
- Non Alcoholic Fatty Liver Disease Influence of Statin TherapyWithdrawnNCT00375349Not applicable
- End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)CompletedNCT00374582Not applicable
- A Study Of GW406381 In Volunteers With Moderate Hepatic ImpairmentCompletedNCT00373243Phase 1
- TachoSil Paediatric Liver Trial (TC-019-IN)CompletedNCT00365248Phase 3
- Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral TherapyCompletedNCT00326482
- Metformin in Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT00303537Phase 2/3
- Selenium Supplementation of Patients With CirrhosisTerminatedNCT00271245Not applicable
- Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the LiverNo longer availableNCT00263978
- Transplant and Addiction Project (TAP) - 1CompletedNCT00249652Phase 1/2
- Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT00247117Not applicable
- Ischemic Preconditioning of Liver in Cadaver DonorsCompletedNCT00245830Not applicable
- Development of a Breath Test for Monitoring Patients With Liver DiseaseCompletedNCT00244569Phase 3
- Transplant Patient Registry of Liver, Kidney and/or PancreasCompletedNCT00238693
- Health Behavior Feedback Study for Veterans With Hepatitis CCompletedNCT00229580Phase 1
- HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B InfectionTerminatedNCT00228592Phase 2
- Qidong Hepatitis B Intervention StudyCompletedNCT00222664Phase 4
- Quantitative Diagnosis of Fatty Liver by Dual Energy CT TechniqueStatus unknownNCT00172705
- Urotensin II and Vascular Tone in CirrhosisStatus unknownNCT00163995
- A Phase II Study of DMP 115 to Assess Focal Liver LesionsCompletedNCT00162058Phase 2
- Intravenous-Morphine and Glucagon-Usage Enhanced MR CholangiographyStatus unknownNCT00155376Phase 4
- Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional InterventionsTerminatedNCT00152815Phase 2
- Orthotopic Liver Transplantation Using a Living DonorTerminatedNCT00152607Phase 4
- Improving Hepatitis C Treatment in Injection Drug UsersCompletedNCT00148031Phase 4
- Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant RejectionCompletedNCT00117689Phase 2
- Bortezomib in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00091117Phase 1
- Kidney and Liver Transplantation in People With HIVCompletedNCT00074386
- The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in DiabeticsTerminatedNCT00068094Phase 1/2
- Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver TransplantCompletedNCT00063648Phase 1
- Hepatic Artery Infusion of CD34+ CellsWithdrawnNCT00062543Phase 1
- Gabapentin to Treat Itch in Patients With Liver DiseaseCompletedNCT00058890Phase 3
- S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionCompletedNCT00049400Phase 1
- Irinotecan in Treating Patients With Refractory Solid Tumors and Liver DysfunctionCompletedNCT00037804Phase 1
- Total Parenteral Nutrition-Associated Liver DiseaseTerminatedNCT00031135Phase 2
- Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
- Mechanisms of Inflammatory Liver InjuryCompletedNCT00011284
- Oxaliplatin to Treat Advanced Cancers With Liver DysfunctionCompletedNCT00006062Phase 1
- Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of ColonizationStatus unknownNCT00005667
- Genetics of Hepatitis C Virus InfectionCompletedNCT00005657
- Natural History of Post-transfusion Non-A, Non-B HepatitisCompletedNCT00005306
- Hepatitis Delta Infections in HemophiliacsCompletedNCT00005305
- Delta Hepatitis and Liver Disease in HemophiliacsCompletedNCT00005304
- Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver DysfunctionCompletedNCT00005077Phase 1
- Magnetic Resonance Imaging of Blood Flow in the Liver and AbdomenCompletedNCT00001719
- Diagnosis and Treatment of Patients With Cystic FibrosisTerminatedNCT00001223
- A Study of Zidovudine in HIV-Infected Patients With Liver DiseaseCompletedNCT00001001Not applicable
- Hepatitis B Vaccine Clinical TrialCompletedNCT00000583Phase 3
- Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune GlobulinCompletedNCT00000580Phase 3